feed,title,long_url,short_url
Benzinga,FDA Issues 'Refusal To File' To Allarity Therapeutics' Dovitinib In Kidney Cancer,https://benzinga.com/general/biotech/22/02/25743729/fda-issues-refusal-to-file-to-allarity-therapeutics-dovitinib-in-kidney-cancer,https://bit.ly/3Idq2cT
